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A novel lectin from the mushroom Marasmius oreades (MOA) has been shown to bind to human blood group B oligosac-
charides [1]. In the present work we examine the binding of a series of analogues of the blood group B-trisaccharide,
αGal(1-3)[αFuc(1-2)]βGal-OR (1, R = (CH2)8COOMe). MOA was biotinylated and immobilized on a micro column (9.8 µL)
for evaluation by Frontal Affinity Chromatography-Mass Spectrometry (FAC-MS) [2]. The trisaccharide 1 was found to be the
epitope needed for maximum recognition (Kd = 3.6 µM). A series of synthetic deoxygenated and O-methylated analogues
of the B-trisaccharide (R = OMe) were then screened against the lectin, and the key structural elements for binding were
determined. OH-4 of the β-Gal residue and OH-2 of the α-Gal residue were found to be critical for recognition. The FAC-MS
technique also proved powerful in evaluating mixtures of compounds. Since the solution NMR structure and crystal struc-
ture of the B-trisaccharide are known [3], we propose the specific surface of the trisaccharide that is recognized by the lectin.
Published in 2003.
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Introduction
Lectins are proteins or glycoproteins which have the rather re-
markable property of binding carbohydrates in a very specific
manner. Some lectins recognize sequences of two or more sac-
charides with specificity toward both inter-residue glycosidic
linkages and anomeric configuration. For these reasons, lectins
have proved to be useful reagents for the identification, isolation
and characterization of the carbohydrate residues of glycocon-
jugates [4].
Frontal affinity chromatography coupled to online electro-
spray mass spectrometry (FAC-MS) is a method that has previ-
ously been applied to characterize lectin-carbohydrate interac-
tions [5]. FAC-MS allows for the rapid screening of mixtures of
compounds, and can be used to estimate the dissociation con-
stant (Kd ) for protein-ligand interactions for each individual
compound present in a mixture [2,6].
Winter et al. recently reported a novel lectin from the
Marasmius oreades mushroom (MOA) and determined its bind-
∗Author to whom correspondence should be addressed.
ing specificity by agglutination studies and in solution by
isothermal titration calorimetry [1]. The lectin was found to
be specific to the carbohydrate portion of the human blood
group B antigen. In the present work, we immobilized the
MOA and by screening a series of structural analogues using
FAC-MS, further characterized the binding specificity of the
lectin.
Materials and methods
The MOA was biotinylated according to the procedure of
Mo et al. [7]. The synthetic carbohydrates used (Figures 1
and 2) were available from previous work [8–10]. PEEK
(polyetheretherketone) tubing, union and tee were from Fischer
Scientific Ltd. and were used in all components of the chro-
matography. The column was prepared by packing controlled
pore glass beads with streptavidin covalently attached (CPG-SA
37–74 µm, CPG Inc., USA) into a 5 cm length of PEEK tubing
(column ID = 0.50 mm), blocked at both ends by a stainless
steel frit (10 µm screen, Valco Instruments Co. Inc.), to form
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Figure 1. Structures and Kd values of the oligosaccharides used to determine the minimum binding domain for MOA.
Figure 2. Structures and Kd values of the oligosaccharide analogues used to map the binding domain of MOA. Structural differences
from 6 have been highlighted.
a column with an internal volume of 9.8 µL. The biotinylated
protein was loaded by injection at 8 µL/min of a protein solu-
tion (0.1 mg/mL in phosphate buffered saline) until the column
was saturated. Remaining streptavidin binding sites were then
blocked by subsequent injection of d-biotin (0.2 mg/mL, 1 mL
in PBS buffer at 8 µL/min). The column was subsequently equi-
librated with ammonium acetate buffer (10 mM, 1 mM NaCl,
pH 7.2) and stored at 4◦C.
Characterization of the recognition of blood group B trisaccharide derivatives 177
Solutions were injected continuously using a multi-syringe
pump (PHD 2000, Harvard Apparatus) into a flow selection
valve (Rheodyne, model 9725) then into the MOA column.
The post column eluent was mixed with an equal amount of
HPLC Grade acetonitrile then sprayed into the sample inlet of
a Hewlett-Packard series 1100 MSD single quadrapole mass
spectrometer.
Three syringes were mounted on the pump; these contained
the analyte solutions in buffer (10 mM NH4OAc, 1 mM NaCl,
pH 7.2), pure buffer and acetonitrile, respectively. The contents
of the three syringes were continuously injected at 8 µL/min
into the flow selection valve. Only one of the buffer or analyte
solutions was injected into the column, the other going to waste.
After each run, the column was re-equilibrated by passing buffer
through it with online monitoring until it was verified that the
analyte had been removed from the column.
Solutions were characterized first by analysis by the mass
spectrometer in scan mode from m/z 100 to 1500 in 1.5 s in
positive ion mode. Once the target ions were detected as their
sodium adducts, they were monitored online in selected ion
monitoring (SIM) mode to improve sensitivity. The nebulizer
was held at a constant voltage (4000 V) with 480 mbar positive
pressure from N2. N2 drying gas was flowed through at 4 L/min.
All retention volumes were calculated by comparing the mid-
point of the analyte elution curve to that of the void marker.
All data was processed with Microsoft Excel, and figures are
presented as IGOR files.
Results and discussion
Figure 3 shows the composite intensity of the m/z signal vs.
time chromatogram of two individual runs in which equimolar
solutions of compounds 1–4 and 1–3 + 5 were run as mix-
tures with 15 as a void volume marker in each solution. It
was necessary to run two mixtures because 4 and 5 share the
same m/z ratio. As 1 and 4 co-elute, it can be seen that the
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Figure 3. Composite FAC-MS chromatogram of two equimolar
mixtures of 1–4 and 1–3 + 5 run through the MOA column.
no further increase in binding affinity. This indicates that the
B-trisaccharide portion is sufficient for full recognition, in
agreement with previously reported data [1]. Compound 5
shows a decreased affinity, as it elutes before 1. This suggests
that there are some unfavorable interactions when changing the
first inter-sugar glycosidic linkage from a β (1–4) linkage to a
β (1–3) linkage. Since 2 had no binding detectable by our sys-
tem, this indicates that the terminal α-Gal residue is critical for
recognition. The Kd value for 3, which lacks the α-Fuc residue,
is approximately 3.5 times larger than for 1. This indicates that
the α-Fuc residue contributed to the binding but that it is not
essential.
The column capacity was determined by injecting solutions
of varying concentrations of 1 and measuring the corresponding
shift in retention volume. The relationship between concentra-
tion and retention volume is governed by Eq. (1), in which
Kd represents the dissociation constant, Vx − Vo the difference
between the void volume and the retention volume of the com-
pound, [Xo] the concentration of the analyte compound and
Bt represents the number of active protein binding sites on the
column.
Vx − Vo = Bt
[Xo] + Kd (1)
By plotting a graph of ([Xo]−1)(V − Vo)−1 vs. [Xo]−1, the Kd
for a particular compound and the Bt for the column can be
determined from the slope divided by the intercept and the re-
ciprocal of the intercept respectively [11].
Figure 4 shows the graph of Eq. (1) for the MOA column
constructed using 15 as a void volume marker and 1 as a ligand.
A dissociation constant of 5.2 µM and a Bt value of 1230 pmol
were derived from the graph. This Kd value agrees well with
the dissociation constant of 3.6 µM presented in Figure 1 as
described below.
Figure 5 shows an intensity vs. time chromatogram in which
compounds 1 and 6 were run competitively with 15 as a void
volume marker. This figure clearly shows the increase in binding
affinity that accompanies the addition of the hydrophobic MCO
aglycone at the reducing end of the trisaccharide in 1. The
signal from 6 is being “rolled up” (i.e. increases in intensity
beyond that of the solution being injected before returning to the
equilibrium intensity) by 1, which indicates competition for the
same binding site on the protein with 1 having a greater affinity
for the MOA [12]. We propose that this increased affinity may be
attributed to the increased hydrophobicity of the MCO aglycone
relative to a simple methyl group. This is likely due to direct
interactions between a hydrophobic pocket on the protein and
the lipidic aglycone.
Figure 6 shows the overlay of the intensity vs. time chro-
matograms for compounds 1, 2, and 6–15 run individually and
presented as a single figure. These compounds are analogues
of 6, with varying substitutions or deoxygenations at differ-
ent positions. Many of these compounds were available with a
13C label in the O-methyl group for use in NMR studies. Each
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Figure 5. FAC-MS chromatogram of an equimolar solution of 6
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Figure 6. Overlaid chromatograms from individual FAC-MS
runs using single 2 µM solutions of 1, 2, and 6–15 flowed through
the MOA column.
compound was run individually as a 2 µM solution with 15 as
the void volume marker. Solutions were run sequentially fol-
lowed by online monitoring of the equilibration of the column
with buffer to fully elute the compound. The elution profile for
15 is only displayed once, as it was invariant in all runs. Dif-
ferences in individual retention volumes, compared to that of
15, yielded an estimate for the individual Kd values using the
Bt value previously obtained. The value for 1 calculated in this
manner, 3.6 µM, also agrees well with the graphically obtained
value of 5.2 µM.
The analogues appeared to fall into three groups. The first
group contained compounds that had very small change (rel-
ative to the parent 6) in affinity for the protein. This in-
cluded compounds 7–10. The chromatogram for 10 demon-
strated a biphasic shape, indicating a mixture of compounds
at m/z = 512 (M + Na+). A 600 MHz 1H-NMR spectrum
of this sample revealed that the terminal Gal residue was
present as an α/β mixture (data not shown), with the desired
α anomer as the major component. A compound in which
the α-Fuc residue was deoxygenated at the 2-position was
unavailable.
In the second group, compounds 11 and 12 demonstrated a
noticeable loss in affinity, indicating that substitutions at C-3
and C-5 of the α-Gal residues are detrimental to binding, but not
critically. Finally, the structural changes in 13 and 14 resulted
in compounds whose binding can barely (if at all) be detected
using the present method, and which we correspondingly de-
scribe as inactive. It is known that the protein does not bind
the blood group A trisaccharide (containing terminal GalNAc
instead of Gal) [1]. Taken together, these results suggest that
OH-4 on the β-Gal and OH-2 on the α-Gal residues are critical
for binding to the protein.
Figure 7 shows the intensity vs. time chromatogram of a
single run in which an equimolar mixture of compounds 1
and 6–15 was injected in a single run. This creates a solu-
tion of twelve potential ligands in addition to the void vol-
ume marker 15, as 10 exists as a mixture of compounds
as described above. The signal for 12 can be seen to “roll
up,” or increase in intensity beyond the intensity correspond-
ing to the infusion concentration before leveling off again
at this level. This phenomenon has been attributed [12] to


























Figure 7. FAC-MS chromatogram obtained when a single,
equimolar solution of 1, 6–15 is flowed through the MOA
column.
the compound being concentrated by the receptor-sites on
the column, and then eluted as a more concentrated solution
by a tighter binding ligand present in the mixture. Despite
the presence of twelve ligands in solution, the FAC-MS sys-
tem still retains the ability to discriminate between the com-
pounds as the order of elution parallels their binding affinity
as determined from the individual runs. This experiment is in-
cluded to demonstrate the power of FAC-MS in dealing with
mixtures.
Finally, the crystal and the solution phase conformation of
the B-trisaccharide has been determined and is reproduced in
Figure 8 [3]. We therefore propose the binding surface presented
for recognition by the protein. OH-2 on the α Gal residue and
OH-4 on the β Gal residue are critical for recognition. The
crystal structure of 6 shows these to be in close proximity in
space (4.21 Å), suggesting that they are forming so-called “key
polar interactions” with the protein [13]. Changes made to the
Figure 8. Crystal structure of the blood group B trisaccharide,
with hydrogen atoms omitted for clarity. (From Otter et al.) Ar-
rows point to essential OH groups in terminal and subterminal
Gal residues.
fucose residue did not result in any appreciable loss of affinity,
suggesting that this sugar residue remains in contact with water.
Other substitutions on the two galactose portions of the trisac-
charide were tolerated with either a slight increase in binding
affinity in the case of 7, or a decrease in binding affinity for 11
and 12. The approximately five-fold decrease in affinity for 11
and 12 suggests that OH-3 and OH-6 on the α Gal residue may
be forming hydrogen bonds near the periphery of the binding
site.
Conclusions
In this work, we examined the binding of a series of struc-
tural analogues of the blood group B trisaccharide, α Gal (1-3)
[α Fuc(1-2)] β Gal, to the lectin from the Marasmius oreades
mushroom. OH-2 on the α Gal and OH-4 on the β Gal residues
were found to be critical for binding. The protein appeared
to be either completely or partially tolerant towards removal
of other hydroxyl groups. From the permitted substitution pat-
terns observed and the previously known crystal structure of the
B-trisaccharide, we are able to propose a binding surface of the
carbohydrate to the protein.
We further show the power of the FAC-MS technique by
demonstrating the ability to discriminate among many com-
pounds in a single run. A single injection of all of the structural
analogues studied was able to resolve the compounds, which
eluted in the order predicted by their individually determined
dissociation constants.
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